Recent Finacing
Recent Raise
RespireRx Pharmaceuticals is a biopharmaceutical company developing selective GABAkine compounds, such as KRM-II-81, for epilepsy and other neurological and psychiatric disorders.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at RespireRx Pharmaceuticals.
